Lunch Session 6 – XXXX

12:30-14:30   Tuesday, 25 April, 2017
Lunch Session Pfizer-Hall H
Unresolved Issues in Anticoagulation Management of Patients with Atrial Fibrillation
 Time TopicSpeaker
12:30-13:00Lunch first and main courses 
13:00-13:25Which anticoagulant to whom?Hans-Christoph Diener
13:25-13:40NOACs Dose Selection; Real Life Considerations or Adherence to GL?Eli Lev
13:40-13:55My patient is well controlled on VKA; why switch?Doron Zahger
13:55-14:10Panel discussion/ Q&APanel chairperson: 
Michael Glikson

To Register Click Here